MedImmune’s Cambridge UK medical technology hothouse will be part of an historic tie-up between the business and the Brazilian government’s ‘Science Without Borders’ programme.
MedImmune, the global biologics research and development arm of AstraZeneca, says that 30 Brazilian post-doctoral fellows will work at its sites in Maryland, California and Cambridge, UK for a period of two years.
{iframe}http://www.businessweekly.co.uk/biomedtech-/16315-medimmune-in-cambridge-brazil-research-alliance{/iframe}